Psilocybin therapy in New York is gaining significant attention as a potential treatment for a variety of mental health conditions. This innovative approach involves the use of psilocybin, a naturally occurring psychedelic compound found in certain mushrooms, combined with professional therapeutic support. Psilocybin therapy has shown promise in treating depression, anxiety, PTSD, and other disorders, offering a new frontier in mental health care. In this guide, we’ll cover the basics of psilocybin therapy, its legal status in New York, and the most reputable centers offering this treatment.
Psilocybin Therapy: An Overview
What is Psilocybin (“Magic Mushrooms”)?
Psilocybin is a naturally occurring psychoactive compound found in certain species of mushrooms. Once ingested, it is converted in the body to psilocin, the active chemical responsible for its auditory and visual effects. Psilocybin primarily works by stimulating serotonin receptors in the brain, particularly the 5-HT2A receptor, which plays a role in mood regulation, perception, and cognition. This interaction can lead to altered states of consciousness, enhanced emotional insight, and a deep sense of connection, which may form the basis for its therapeutic potential.
, a set of brain areas related to self-referential thought processes. Overactivity in this network is associated with conditions like depression. By reducing DMN activity, psilocybin enhances communication between brain regions, promoting more integrated neural function, which may lead to improved emotional processing and cognitive flexibility.
Neuroplasticity and Synaptic Growth
One of psilocybin’s most promising effects is its ability to stimulate neuroplasticity, promoting the formation of new neural pathways. Research shows that psilocybin increases brain-derived neurotrophic factor (BDNF), crucial for neurogenesis and synaptic growth. This enhanced neuroplasticity may help individuals break rigid cognitive patterns linked to mental health disorders, supporting long-term improvements in emotional and cognitive health.
Read: Psilocybin and Neuroplasticity: Research & Benefits
Psilocybin for Mental Health
Psilocybin therapy has shown significant promise as an alternative treatment for various mental health disorders, particularly depression, end-of-life anxiety, post-traumatic stress disorder (PTSD), obsessive-compulsive disorder (OCD), eating disorders, and substance use disorders. Studies indicate that psilocybin can facilitate profound psychological breakthroughs when administered in a therapeutic setting, offering new avenues for addressing these health conditions.
Depression
One of the more robust findings in psilocybin research has been its effectiveness in treating major depressive disorder (MDD) and, to a lesser extent, treatment-resistant depression (TRD). Clinical trials, such as those conducted by Johns Hopkins University and Imperial College London, have demonstrated that psilocybin-assisted therapy can lead to significant and long-lasting reductions in depressive symptoms. In one study, a single dose of psilocybin, combined with psychotherapy, resulted in a marked decrease in depression severity, with effects lasting up to 12 months in many participants.
Anxiety
Psilocybin has also been explored for its potential in treating anxiety disorders, particularly in individuals facing life-threatening illnesses. A groundbreaking trial conducted at NYU Langone Health showed that psilocybin-assisted therapy significantly reduced anxiety in patients with terminal cancer. The patients not only reported reduced fear and anxiety surrounding death but also experienced improvements in overall well-being.
Post-Traumatic Stress Disorder (PTSD)
Early research suggests that psilocybin may be an effective alternative treatment for PTSD. Clinical trials have demonstrated that psilocybin-assisted therapy helps patients process traumatic memories and emotions in a supportive environment. Psilocybin’s ability to promote emotional reconsolidation and cognitive flexibility makes it a promising candidate for reducing avoidance behaviors and facilitating emotional healing in PTSD patients. By disrupting patterns of fear-based responses, psilocybin allows patients to reprocess traumatic experiences with reduced distress.
Substance Use Disorders
Another promising application of psilocybin is in the treatment of substance abuse. Studies from Johns Hopkins University have shown that psilocybin can significantly reduce tobacco and alcohol dependence. In one trial, 80% of participants who underwent psilocybin-assisted therapy successfully quit smoking after six months. Similar findings have been reported for individuals struggling with alcohol addiction, with many participants showing reduced alcohol consumption and sustained abstinence after psilocybin therapy. The drug appears to facilitate cognitive and emotional insight, helping individuals identify and address the root causes of their addictions.
Read: Psilocybin Therapy for Depression and Psilocybin Therapy for Obsessive-Compulsive Disorder (OCD)
![Therapeutic Benefits of Psilocybin infographic with sage green gradient design highlighting brain effects, mental health applications, and neuroplasticity. Features immediate and lasting benefits for depression, anxiety, and PTSD](/assets/images/articles/mushrooms-in-california/692e9e11584cc866b2f1505f-infographic-9-therapeutic-benefits-of-psilocybin.webp
Therapeutic Benefits of Psilocybin infographic with sage green gradient design highlighting brain effects, mental health applications, and neuroplasticity. Features immediate and lasting benefits for depression, anxiety, and PTSD
Psilocybin-Assisted Services: What to Expect
The therapeutic process of psilocybin experiences is often broken down into several stages to ensure both safety and effectiveness for the user:
- Exploration Call: The therapy process may begin with an exploration call where a trained facilitator gathers information about the participant’s background, mental health history, and goals. This helps build rapport and sets a supportive environment for the upcoming therapy.
- Safety Screening: After the initial consultation, participants may undergo a health screening to identify any medical risks. Chronic conditions or medications could interfere with the treatment, so facilitators ensure participants are safe to proceed. Concerns are addressed at this stage.
- Preparation: If the screening clears, participants engage in one or more preparation sessions with their facilitator. In these discussions they can ask questions, confirm their comfort with the process, and finalize the therapy logistics. The facilitator will outline expectations and review any preparatory work.
- Psilocybin Session: During the session, participants receive a controlled dose of psilocybin, guided by a facilitator who ensures their safety and provides support throughout the experience. The total time commitment varies in length, depending on whether it’s a single-day private session or a multi-day group retreat. Participants are encouraged to reflect on their thoughts and emotions, with the facilitator guiding them through difficult moments.
- Integration: After the session, participants move into the integration phase, where post-session discussions with the facilitator help them process their experiences and insights. Integration is critical for applying these insights to their mental health and daily life, fostering lasting change.
![New York’s current psilocybin legislation landscape infographic showcasing pending medical therapy bills, treatment applications including depression and PTSD, legalization status versus Oregon and Colorado, and U.S. public perception data. Created by Odyssey Public Benefit Corporation with Statue of Liberty imagery.](/assets/images/articles/mushrooms-in-new-york/692eb3f44c30f46dd5e636d6-infographic-11-psilocybin-in-ny-insights.webp
Legal Status of Psilocybin in New York
In New York, psilocybin remains illegal, classified as a Schedule I controlled substance under the New York Controlled Substances Act. This classification places it in the same category as drugs like heroin, LSD, and MDMA. Schedule I substances are considered to have a high potential for abuse and no currently accepted medical use under federal law. As a result, the possession, sale, or distribution of psilocybin in New York is illegal and can carry severe legal penalties.
However, as of February 2025, New York State is actively considering legislation to legalize psilocybin-assisted therapy. On January 8, 2025, Senator Nathalia Fernandez introduced Senate Bill S495, which aims to amend the public health law to permit the medical use of psilocybin. The bill proposes the establishment of licensed facilitators authorized to administer psilocybin-assisted therapy to qualified patients, reflecting a growing recognition of psilocybin’s potential therapeutic benefits for various mental health conditions.
As the legislative process unfolds, it is crucial for stakeholders and the public to stay informed about developments surrounding psilocybin policy in New York. The proposed bills represent a significant shift in the approach to mental health treatment, emphasizing the potential of psychedelic-assisted therapy. Continued dialogue and research will play vital roles in shaping the future of psilocybin use within the state’s healthcare system.
Read: Are Mushrooms Legal in New York? What to Know in 2025
How to Access Psilocybin Therapy in New York
As psilocybin therapy gains traction across the U.S., New York is becoming a center of interest due to its growing mental health crisis and the need for innovative treatment options. Psilocybin therapy offers a promising approach for conditions like depression, anxiety, PTSD, and substance use disorders. With ongoing clinical research, New York is home to several institutions conducting groundbreaking studies on the efficacy of psychedelic drugs for mental health.
![Guided psilocybin treatment infographic on serene landscape background illustrating medical screening, therapeutic session protocols, and integration benefits. Features three-phase healing journey](/assets/images/articles/finding-legal-psilocybin-therapy-in-colorado/692e9dcc4c6ad717dde5c1c8-infographic-10-psilocybin-journey.webp
Psilocybin Research
New York has one of the major prestigious centers focusing on psychedelic research and therapy, the Center for Psychedelic Medicine at NYU Langone Health. This center is involved in clinical trials that explore the potential of psilocybin to treat various mental health conditions, including depression and substance use.
Some individuals may qualify to participate in clinical trials as part of ongoing research. As of October 2024, NYU Langone Health is recruiting participants for several trials, including the following:
- Psilocybin-Assisted Therapy for Smoking Cessation
- Psilocybin-Assisted Therapy for Depression and Anxiety in Advanced Cancer
- A Phase 3 Study Psilocybin for the Treatment of Major Depressive Disorder
- Neurobehavioral Mechanisms of Psilocybin-Assisted Treatment for Alcohol Use Disorder
Options for Psilocybin-Assisted Services
For those seeking legal psilocybin-assisted services, there are options available outside of New York. Odyssey offers private sessions and group retreats that are evidence-based and professionally guided. These retreats, hosted in states where psilocybin is legal, provide safe, therapeutic environments for individuals seeking mental health support through psilocybin-assisted services. Get matched to the best experience for you.
Conclusion
Psilocybin therapy is emerging as a transformative approach to mental health treatment, with increasing attention in New York. Although psilocybin remains a Schedule I controlled substance in the state, ongoing research and advocacy efforts are fostering discussions about its therapeutic potential. Institutions such as NYU Langone are at the forefront of clinical trials, contributing valuable data on the efficacy of psychedelic-assisted therapies. As regulations evolve, keeping an eye on legal options and new research developments can be valuable for those exploring innovative mental health solutions.